HealthEquity, Inc.
HealthcareNASDAQ:HQY · NASDAQ Global Select
-$0.62 today
Vol 0.71M · Avg 0.99M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Earnings Waterfall
Revenue to Net Income
Key Ratios
Analysis
$1.3B of revenue converted into $230.7M of net income for the selected period. Gross margin is 72.5% and net margin is 17.2%, showing how much revenue survives after costs and taxes. EPS is $2.67, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.3B +9.5% | $1.2B +20.0% | $999.6M +16.0% | $861.7M +13.9% | $756.6M | $1.0B | $809.6M | $921.6M |
| Cost of Revenue | $400.3M -21.1% | $507.2M +8.0% | $469.7M +0.7% | $466.2M +12.2% | $415.6M | $344.8M | $725.6M | $804.0M |
| Gross Profit | $913.1M +31.8% | $692.6M +30.7% | $529.9M +34.0% | $395.5M +16.0% | $340.9M | $10.3B | $8.9B | $7.6B |
| Gross Margin | 69.5% +11.8pp | 57.7% +4.7pp | 53.0% +7.1pp | 45.9% +0.8pp | 45.1% | 45.5% | 9.8% | 28.9% |
| Research & Development | $262.5M +9.6% | $239.5M +9.5% | $218.8M +13.2% | $193.4M +22.9% | $157.4M | $378.4M | $983.2M | $1.3B |
| Selling, General & Admin | $328.1M +47.2% | $223.0M +21.9% | $182.9M +11.2% | $164.5M +15.0% | $143.0M | $1.4B | $620.6M | $923.0M |
| Operating Expenses | $590.7M +27.7% | $462.5M +15.1% | $401.7M +12.3% | $357.9M +19.1% | $300.3M | $3.6B | $5.3B | $7.0B |
| Depreciation & Amortization | $0 -100.0% | $162.5M +6.1% | $153.1M -5.0% | $161.2M +17.5% | $137.2M | $1.2B | $374.2M | $1.2B |
| EBITDA | $334.6M -0.9% | $337.5M +19.5% | $282.4M +64.6% | $171.5M +66.6% | $103.0M | $12.6B | -$15.2B | $6.8B |
| EBITDA Margin | 25.5% -2.7pp | 28.1% -0.1pp | 28.3% +8.3pp | 19.9% +6.3pp | 13.6% | 10.0% | 5.6% | 46.3% |
| Operating Income | $322.5M +40.2% | $230.1M +79.6% | $128.1M +240.3% | $37.7M -7.2% | $40.6M | $10.6B | $12.3B | $14.0B |
| Operating Margin | 24.6% +5.4pp | 19.2% +6.4pp | 12.8% +8.4pp | 4.4% -1.0pp | 5.4% | 18.7% | 16.6% | 24.1% |
| Interest Income | $12.1M -13.0% | $13.9M +14.6% | $12.1M +588.5% | $1.8M +17.5% | $1.5M | $1.3B | -$1.5B | -$1.6B |
| Interest Expense | $57.1M -5.8% | $60.6M +9.3% | $55.5M +14.5% | $48.4M +32.4% | $36.6M | $969.2M | $1.1B | $1.0B |
| Other Income / Expenses | -$45.0M +60.5% | -$114.0M -114.8% | -$53.1M +29.9% | -$75.7M +29.4% | -$107.3M | -$1.6B | -$1.5B | $1.4B |
| Income Before Tax | $277.4M +139.1% | $116.0M +54.6% | $75.0M +297.0% | -$38.1M +42.9% | -$66.7M | -$15.6B | $3.3B | $4.9B |
| Pre-Tax Margin | 21.1% +11.5pp | 9.7% +2.2pp | 7.5% +11.9pp | -4.4% +4.4pp | -8.8% | 13.3% | 20.8% | 18.7% |
| Income Tax Expense | $62.2M +221.9% | $19.3M +0.0% | $19.3M +261.7% | -$12.0M +46.8% | -$22.5M | $666.8M | $1.3B | -$1.6B |
| Net Income | $215.2M +122.5% | $96.7M +73.6% | $55.7M +313.1% | -$26.1M +41.0% | -$44.3M | $5.0B | $4.9B | $4.8B |
| Net Margin | 16.4% +8.3pp | 8.1% +2.5pp | 5.6% +8.6pp | -3.0% +2.8pp | -5.9% | 7.4% | 12.4% | 17.5% |
| EPS (Basic) | $3 +125.2% | $1 +70.8% | $1 +309.7% | -$0 +41.5% | -$1 | $1.2B | $400.8M | $703.2M |
| EPS (Diluted) | $2 +125.7% | $1 +70.3% | $1 +306.5% | -$0 +41.5% | -$1 | $620.6M | $766.2M | $609.4M |
| Weighted Avg Shares | $86.1M -0.8% | $86.9M +1.5% | $85.6M +1.3% | $84.4M +1.6% | $83.1M | $892.2M | $757.8M | $925.8M |
| Weighted Avg Shares (Diluted) | $87.5M -1.5% | $88.8M +2.2% | $87.0M +3.0% | $84.4M +1.6% | $83.1M | $319.6M | $1.2B | $924.4M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
DaVita Inc.
NYSE:DVA
$13.40B
Penumbra, Inc.
NYSE:PEN
$12.54B
BrightSpring Health Services, Inc. Common Stock
NASDAQ:BTSG
$12.26B
Globus Medical, Inc.
NYSE:GMED
$10.84B
Molina Healthcare, Inc.
NYSE:MOH
$10.43B
Henry Schein, Inc.
NASDAQ:HSIC
$9.26B
Corcept Therapeutics Incorporated
NASDAQ:CORT
$8.90B
Bio-Rad Laboratories, Inc.
NYSE:BIO
$7.73B
Hims & Hers Health, Inc.
NYSE:HIMS
$5.98B
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does HQY generate?
HealthEquity, Inc. (HQY) reported $1.31B of revenue in fiscal 2026.
Is HQY profitable?
HealthEquity, Inc. (HQY) reported $215.20M of net income, with a net margin of 16.4%.
Explore More
Continue the stock analysis
Jump to another research area for this company.